Day Range:
Last Trade Time:
Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Latest News
Likes Subject
https://www.otcmarkets.com/filing/html?id=16234202&guid=QbG-keoFaVaqJth Scuba2 11/30/22 10:53 AM
https://www.prnewswire.com/news-releases/cnbx-to-enter-the-cancer-immunotherapy- Scuba2 11/08/22 10:46 AM
CNBX Files New PCT Patent Application For Cannabinoids-Based Dean14 10/18/22 9:13 AM
They might just be riding the MJ wave, GoSing 10/14/22 2:09 AM
October 10th was almost a dollar higher than jim992 10/13/22 10:38 PM
Wow what an up day. GoSing 10/13/22 8:21 PM
Here is a link to an interview. She GoSing 09/30/22 6:32 PM
I am concerned that we don't have a GoSing 09/30/22 6:30 PM
@gosing the New CTO is Dr. Sanja Goldberg. Scuba2 09/30/22 12:33 PM
So whos running the ship now that Eyal GoSing 09/30/22 10:41 AM
https://www.prnewswire.com/news-releases/cnbx-peer-reviewed-study-possible-futur Scuba2 09/30/22 6:07 AM
https://www.prnewswire.com/il/news-releases/cnbx-pharmaceuticals-announces-new-p Scuba2 09/29/22 3:09 AM
I am one of those long-term guys you jim992 09/14/22 12:04 AM
There is no recovering from 1 for 120 truffleberry 09/13/22 9:27 AM
This forum as I remember was never very truffleberry 09/13/22 9:26 AM
This stock continues to piss me off GoSing 09/12/22 9:48 PM
WOW!! 1/3rd of our value in a jim992 09/12/22 5:21 PM
Anyone else getting a PAGE EXPIRED page when jim992 09/12/22 5:20 PM
I'll save them for when the toilet paper GoSing 09/09/22 12:08 PM
I think we're already here. 94% paper-loss, what's truffleberry 09/09/22 10:36 AM
Stick a fork in us. We're done. GoSing 08/05/22 8:26 PM
So any ideas when the shares become worthless GoSing 08/01/22 7:57 PM
It had some action before, now it's completely truffleberry 07/26/22 1:28 PM
38 is my break even. I tried to XWAVXALMIMAN 07/25/22 9:27 PM
Jesus H Christ. What in the hell did GoSing 07/25/22 9:09 PM
Relevant portion of todays 8-K: truffleberry 07/25/22 1:37 PM
Biotech has lots of blue sky potential… it’s WallyWest 07/18/22 5:57 PM
I would need this thing to reach $43 GoSing 07/15/22 8:00 PM
Yeah we're screwed. GoSing 07/15/22 7:53 PM
It looks like long timers are fucked eitherway, truffleberry 07/15/22 1:36 PM
We need to get some drugs approved by GoSing 06/30/22 11:23 PM
Probably right, another MJ company that rode the truffleberry 06/30/22 10:43 AM
My wife talked me into doing the same. jim992 06/30/22 1:10 AM
I feel your pain. My 18000 shares went GoSing 06/29/22 10:13 AM
"And not good toast like cinnamon toast, but jim992 06/29/22 12:46 AM
This stock is toast. And not good toast GoSing 06/28/22 9:49 PM
Several days of sitting at $ 3.75 with jim992 06/28/22 12:47 PM
I'm confused. Are you having a conversation with GoSing 06/09/22 8:31 PM
Last message before I take a seat and XTRR 06/09/22 2:32 AM
Scared you sold and cut your loss? Call XTRR 06/09/22 2:23 AM
I check my account everyday, every night, almost XTRR 06/09/22 2:22 AM
https://media.gq.com/photos/58dd6d0ebf444b06a49ccfbe/16:9/pass/scarlett_joh XTRR 06/09/22 2:18 AM
Your (our) support gets a dividend. Think it'll XTRR 06/09/22 2:13 AM
The 1-120 reverse split was announced on Thursday, XTRR 06/09/22 2:10 AM
Feel like someone stole your money, then Rsplit XTRR 06/09/22 1:54 AM
https://www.google.com/search?q=cnbxd+stock+price&source=hp&ei=z4qhYrzKBaqfqtsP8 XTRR 06/09/22 1:53 AM
https://www.bing.com/search?q=cnbx+stock+price&form=ANNTH1&refig=0d6b27bb35e4435 XTRR 06/09/22 1:53 AM
Could that be why we changed from CNBX XTRR 06/09/22 1:51 AM
I didn't have many shares but I did XTRR 06/09/22 1:47 AM
I have video of the data before the XTRR 06/09/22 1:42 AM
Likes Subject

10/14/22 2:09 AM
10/13/22 8:21 PM
09/30/22 6:32 PM
09/30/22 6:30 PM
09/30/22 10:41 AM
09/14/22 12:04 AM
09/13/22 9:27 AM
09/13/22 9:26 AM
09/12/22 9:48 PM
09/12/22 5:21 PM
09/09/22 12:08 PM
08/05/22 8:26 PM
07/26/22 1:28 PM
07/25/22 9:27 PM
07/25/22 9:09 PM
07/25/22 1:37 PM
07/15/22 8:00 PM
07/15/22 7:53 PM
07/15/22 1:36 PM
06/30/22 11:23 PM
06/30/22 10:43 AM
06/30/22 1:10 AM
06/29/22 10:13 AM
06/28/22 9:49 PM
06/28/22 12:47 PM
06/09/22 1:47 AM
06/09/22 1:42 AM

CNBX Pharmaceuticals Inc. (CNBX)

Posts (Today)
Posts (Total)





***4/12/2017 NEWS UPDATE*** 

FORBES.COM:  CNBX Added To The U.S. Marijuana Index
LINK:  https://www.forbes.com/sites/debraborchardt/2017/04/12/here-are-the-5-stocks-added-to-the-u-s-marijuana-index/#42c4f3d452e7

***4/7/2017 NEWS UPDATE*** 

Reports Success From Recent Cannabis Study On Cancer

LINK:  http://goo.gl/EIHBuC

***4/3/2017 NEWS UPDATE*** 

Cannabics Pharmaceuticals Inc. Receives the Final Report of Its
Research on Antitumor Properties of Cannabinoids Held in Israel

Itamar Borochov, CEO of Cannabics Pharmaceuticals said, "The results from this research strengthen our vision of creating anticancer treatments based on natural cannabis medicine".

LINK:  http://goo.gl/WXOXhW

Bringing Cannabinoid Diagnostics to Personalized Cancer Care

Cannabics Pharmaceuticals Inc. (CNBX), a U.S-based public company, is dedicated to the development of personalized diagnostic tools, aimed to provide supportive data for practitioners and patients regarding cannabinoid based therapy. The Company’s R&D is based in Israel, where it is licensed by the Ministry of Health for its work in both scientific and clinical research. The Company’s focus is on harnessing the therapeutic properties of natural Cannabinoid formulations. Cannabics engages in delivering the maximum amount of supportive data for cancer patients and their doctors, utilizing advanced screening systems and personalized bioinformatics tools.

View entire 24 page presentation : http://cannabics.com/presentation/

Cannabics SR' CAPSULES

Long acting oil capsule that provides a safe, effective and reliable administration of cannabis.

Cannabics SR' Capsules, Technology Description - Route of administration
There is a growing number of patients, worldwide, who could benefit from the therapeutic properties of cannabinoids. The unmet need of these patients is a safe, standardized and easy to administer cannabinoid-based therapy. Cannabinoid administration is mainly through smoking, vaporizing, sublingual and oral. While clinical studies show contradictory data regarding a correlation between smoking cannabis and respiratory diseases, most physicians agree that smoking medical cannabis, while having its benefits, is not a healthy nor standardized therapy. 

The pharmacokinetics of THC varies as a function of its route of administration. Pulmonary assimilation of inhaled THC causes a maximum plasma concentration within minutes; psychotropic effects start within seconds to a few minutes, reach a maximum after 15–30 minutes, and taper off within 2–3 hours. Following oral ingestion, psychotropic effects set in with a delay of 30–90 minutes, reach their maximum after 2–3 hours and last for about 4–12 hours, depending on dose and specific effect. Another common route of administration is sublingually. Pure cannabinoids are extracted from the raw plant, dissolved in different oils and administered with a dropper. The beneficial effect of sublingual oil administration is 2-4 hours with a fast onset due to quick absorption through the oral cavity.

The most common oral administration of cannabinoids is through eating edibles, mainly, cookies, chocolate bars and lozenges. Since absorption is attenuated when cannabinoids are ingested orally, Edibles usually contain high dosages of cannabinoids (50-300mg). The high dosage may cause undesirable side effects, mainly, dizziness, anxiety and dissociation. These side effects cause many patients to withdraw from the therapeutic process.  The oral administration route has the longest beneficial effect (4-8 hours) and lacks the undesirable effects of smoking.

Technology currently envisions the licensing of three different formulations: capsules with a 10:1 CBD to THC ratio, a 10:1 THC to CBD ratio and a balanced formulation with 1:1 THC:CBD.

Cannabics Pharmaceuticals Inc. does not manufacture, distribute, dispense or possess any controlled substances, including cannabis or cannabis based preparations. 

Cannabics Pharmaceuticals Announces a New Dosage of 5mg THC Cannabis Capsule Treating Cancer Patients Suffering from Cachexia and Anorexia Syndrome...!

BETHESDA, Maryland, Jan. 3, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) today announced development of Cannabics 5mg THC Capsule intended for naïve patient who have not tried cannabis in the past.

Dr. Eyal Ballan, Chief scientist of Cannabics Pharmaceuticals stated, "Our mission is to find the right balance between efficacy on the one hand and the elimination of undesired psychoactive effects on other."

The Cannabics 5mg THC capsule is currently being evaluated by the company in a clinical study as a palliative treatment, which is conducted by the oncology department at the prestigious Rambam Medical Center in northern Israel and under strict regulations of the Ministry of Health, by whom Cannabics Pharmaceuticals has been licensed since 2014.

The study is taking place in Israel, it is fully registered with the US NIH under "Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients", Identifier NCT02359123, and may be found at :


"The majority of our cancer trial patients have no previous experience with Cannabis, hence this recalibration of the THC level may be more amenable. We believe there is a significant potential medical market for our 5mg THC capsule in countries that have now instituted medical cannabis regulations," said Itamar Borochov, CEO of Cannabics Pharmaceuticals Inc.



What is A Cannabinoid?

You’ve heard by now that marijuana is a powerful medicinal herb. But, just how powerful is it? The list of medical benefits for these top 10 cannabinoids seems endless.


Security Details Share Structure
  Market Value1 $72,404,107 a/o Jan 13, 2017
Authorized Shares 900,000,000 a/o Dec 30, 2016
Outstanding Shares 107,265,344 a/o Dec 30, 2016
-Restricted 90,368,887 a/o Dec 30, 2016
-Unrestricted 16,896,457 a/o Dec 30, 2016
  Held at DTC Not Available
Float 14,295,638 a/o Jun 30, 2016
  Par Value 0.0001

CNBX Security Details Share Structure
  Market Value1 $37,994,466 a/o Oct 28, 2016
  Authorized Shares 900,000,000 a/o Jul 09, 2015
  Outstanding Shares 107,026,665 a/o Jun 30, 2016
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float 18,737,071 a/o Jun 30, 2016
  Par Value 0.0001

Most Liked Posts
(Last 30 Days)
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CNBX Latest News
Most Liked Posts
(Last 30 Days)
New Post